2026-05-14T15:13:19-05:00 2025-06-30 341874260 CBIZ ADVISORS LLC 700 WEST 47TH STREET SUITE 1100 KANSAS CITY MO 64112 990 2024-07-01 592193032 LIFELINK FOUNDATION INC LIFE 8132532640 9661 DELANEY CREEK BOULEVARD TAMPA FL 33619 PATRICK BRISLEY CFO 8132532640 2026-05-11 1 1 LISA BURKE P00220718 8169455500 2024 2025-03-06 01:10:19Z STEPHANIE HERNANDEZ 9661 DELANEY CREEK BOULEVARD TAMPA FL 33619 259219883 0 X LIFELINKFOUNDATION.ORG X 1982 FL TO HONOR DONORS AND SAVE LIVES THROUGH ORGAN AND TISSUE DONATION. 18 12 820 250 149845 28448 0 0 158934068 179667851 8571121 25954037 165435 149845 167670624 205771733 468059 240532 0 0 81449483 90839624 0 0 0 74633978 87261293 156551520 178341449 11119104 27430284 291620912 321109450 39870108 45773531 251750804 275335919 X TO HONOR DONORS AND SAVE LIVES THROUGH ORGAN AND TISSUE DONATION. (EXPANDED MISSION ON SCHEDULE O) 0 0 107989240 240532 116421016 LIFELINK FOUNDATION ORGAN PROCUREMENT ORGANIZATIONS: ORGAN DONATION IS ONE OF THE MOST MEANINGFUL, EMOTIONAL, AND VULNERABLE EXPERIENCES A FAMILY CAN FACE. OUR LONGSTANDING PRESENCE IN OUR DONOR SERVICE AREAS MEAN:- FAMILIES KNOW US- HOSPITALS RELY ON US- COMMUNITY PARTNERS VALUE OUR OUTREACH- OUR STAFF REFLECT THE COMMUNITIES THEY SERVE- TRANSPLANT CENTERS TRUST OUR EXPERTISE(CONTINUED ON SCHEDULE O)LIFELINK OF FLORIDA, LIFELINK OF GEORGIA, AND LIFELINK OF PUERTO RICO PARTNER WITH HOSPITALS TO PROVIDE RESOURCES AND COMFORT TO FAMILIES THROUGH THE PROCESS OF ORGAN DONATION IN 15 FLORIDA COUNTIES, THE STATE OF GEORGIA AND TWO COUNTIES IN SOUTH CAROLINA, AND THE COMMONWEALTHS OF PUERTO RICO AND US VIRGIN ISLANDS, RESPECTIVELY. THEY CARRY OUT THE DECISIONS OF REGISTERED DONORS AND THOSE FAMILIES WHO SAID "YES" TO DONATION AND HONOR THE LIFE OF EACH DONOR BY PROVIDING ORGANS FOR TRANSPLANT TO AS MANY PATIENTS AS POSSIBLE.THE ACT OF ORGAN DONATION GIVES PATIENTS WITH CRITICAL CONDITIONS A SECOND CHANCE AT LIFE. ONE ORGAN DONOR CAN SAVE 8 LIVES. THANKS TO A DONOR HERO'S LIFESAVING GIFTS, MANY TRANSPLANT RECIPIENTS GO ON TO LEAD NORMAL, ACTIVE AND PRODUCTIVE LIVES. THANKS TO THE GENEROSITY OF ORGAN DONORS AND THEIR FAMILIES, LIFELINK OF FLORIDA, LIFELINK OF GEORGIA AND LIFELINK OF PUERTO RICO FACILITATED 2,645 LIFE-SAVING ORGAN TRANSPLANTS DURING THE 2025 FISCAL YEAR, REPRESENTING OVER 5% OF ALL TRANSPLANTS PERFORMED IN THE UNITED STATES. EACH LIFELINK OPO CONTRIBUTED TO THESE EFFORTS, WITH LIFELINK OF FLORIDA FACILITATING RECOVERY OF 356 DONORS, LEADING TO 959 ORGANS BEING TRANSPLANTED. LIFELINK OF GEORGIA TRANSPLANTED 1,388 ORGANS FROM THE RECOVERY OF 446 DONORS. LIFELINK OF PUERTO RICO RECOVERED FROM 115 DONORS AND TRANSPLANTED 298 ORGANS. DONATION RESULTS FROM INTERNAL COLLABORATION, AS WELL AS COLLABORATION WITH PARTNER HOSPITALS AND THE COMMUNITY, IMPLEMENTATION AND EVALUATION OF PROCESS IMPROVEMENT, STAFF COMMITMENT TO EXCELLENCE, AND MOST OF ALL, DONOR FAMILY SUPPORT AND THE FORETHOUGHT OF INDIVIDUALS WHO CHOSE TO JOIN THEIR RESPECTIVE STATE DONOR REGISTRIES.AN EXAMPLE OF COLLABORATION WITH OUR PARTNER HOSPITALS HAS BEEN THE LIFELINK DONOR CARE UNIT AT PIEDMONT ATLANTA HOSPITAL. THE DONOR CARE UNIT ENHANCES THE LIFESAVING GIFTS PROVIDED BY GENEROUS ORGAN DONORS THROUGH EXPERT CLINICAL MANAGEMENT, WHILE CONTINUING TO SUPPORT DONOR FAMILIES THROUGH THE DONATION PROCESS WITH COMPASSIONATE, PERSONALIZED CARE. A SIMILAR CONCEPT OF DEDICATED SPACE HAS BEEN IMPLEMENTED AT TAMPA GENERAL HOSPITAL IN TAMPA, FLORIDA FOR OUR LIFELINK FLORIDA OPO AND AT AUXILLO MUTUO IN PUERTO RICO FOR OUR LIFELINK PUERTO RICO OPO. PARTNERSHIP WITH HOSPITALS DOES NOT END WITH ENGAGEMENT IN CLINICAL DONOR MANAGEMENT AND ORGAN RECOVERY. LIFELINK OPOS ALSO WORKED WITH 383 LOCAL HOSPITALS THROUGHOUT THE FOUNDATION SERVICE AREA TO CREATE A DONATION FRIENDLY COMMUNITY WITHIN HOSPITALS AND THE AREAS WE BOTH SERVE. 48100710 51164636 LIFELINK TISSUE BANK: LIFELINK TISSUE BANK IS A DEDICATED STEWARD OF THE LEGACY ENTRUSTED TO US BY TISSUE DONORS AND THEIR FAMILIES. WE HONOR EACH TISSUE DONOR BY SAFELY PROVIDING AN ENHANCED QUALITY OF LIFE TO AS MANY PEOPLE AS POSSIBLE THROUGH TISSUE TRANSPLANTATION AND INNOVATIVE RESEARCH TO IMPROVE PATIENT CARE. (CONTINUED ON SCHEDULE O) GENEROUS TISSUE DONORS MADE POSSIBLE MORE THAN 83,000 MUSCULOSKELETAL TISSUE GRAFTS TO ENHANCE THE LIVES OF PATIENTS IN NEED OF TISSUE TRANSPLANTATION. ADDITIONALLY, THROUGH BIRTH TISSUE DONATION, THE ONLY DONATION LIFELINK FACILITATES FROM LIVING DONORS, NEARLY 45,000 GRAFTS WERE MADE AVAILABLE TO HELP PATIENTS RECOVER FROM DIFFICULT-TO-HEAL WOUNDS, DIABETIC ULCERS AND DURING OTHER LIFE ENHANCING SURGICAL PROCEDURES.TISSUES RECOVERED BY LIFELINK TISSUE BANK: SKIN: PRIMARILY USED TO ASSIST IN THE HEALING OF BURN PATIENTS BONE: USED FOR A VARIETY OF ORTHOPEDIC AND SPINAL PROCEDURES TENDONS: OFTEN USED ON SPORTS-RELATED INJURIES VALVES: USED COMMONLY IN HEART VALVE REPLACEMENT SURGERIES BIRTH TISSUE: PLACENTAL TISSUE DONATED BY NEW MOTHERS AFTER THE BIRTH OF THEIR BABY AND THE ONLY TISSUE RECOVERED AND PROCESSED BY LIFELINK TISSUE BANK FROM A LIVING DONOR, IS UTILIZED AS A WOUND COVERING. TISSUES PROCESSED AND DISTRIBUTED BY LIFELINK TISSUE BANK: SPINAL GRAFTS: DESIGNED TO PROMOTE FUSION AND HELP PATIENTS WHO SUFFER FROM SEVERE AND/OR CHRONIC PAIN TO LEAD NORMAL LIVES. SPORTS GRAFTS: USED IN JOINT RESTORATION PROCEDURES TO HELP RESTORE MOVEMENT TO PATIENTS SUFFERING FROM PAIN AND DISCOMFORT THAT PREVENTS THEM FROM ENJOYING ACTIVE LIFESTYLES. GENERAL ORTHOPEDIC GRAFTS: HELP TO PROMOTE BONE FORMATION, OPTIMIZE HEALING AND ACCELERATE A PATIENT'S RETURN TO NORMAL FUNCTION. FRESH AMNIOTIC BIRTH TISSUE TO TREAT DIABETIC FOOT ULCERS AND OTHER DIFFICULT TO CLOSE WOUNDS. 12357779 12082199 LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY: LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY BRINGS THE LEGACY ESTABLISHED BY ORGAN DONORS AND THEIR FAMILIES TO LIFE BY SERVING AS THE MATCHMAKER BETWEEN ORGAN DONORS AND POTENTIAL TRANSPLANT RECIPIENTS. WE CONTINUE TO HONOR DONORS BY ENSURING THE LONGEVITY OF RENEWED LIFE WITH DILIGENT POST-TRANSPLANT MONITORING AND INNOVATIVE RESEARCH TO IMPROVE PATIENT CARE. (CONTINUED ON SCHEDULE O)DURING THE 2025 FISCAL YEAR, THE LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY FACILITATED 1,062 LIFESAVING TRANSPLANTS FOR SIX TRANSPLANT CENTERS SERVED. THEY ALSO EVALUATED 545 LIVING DONORS AND 947 DECEASED DONORS AND CONDUCTED OVER 44,000 TRANSPLANT RELATED TESTS. THE LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY UTILIZES HLA TYPING BY NEXT-GENERATION SEQUENCING (NGS) TO BETTER ASSESS THE COMPATIBILITY OF A DONOR AND A POTENTIAL RECIPIENT. RESEARCH AND DEVELOPMENT: THE PRIMARY GOAL OF LIFELINK IS TO RECOVER LIFESAVING ORGANS AND TISSUES FOR TRANSPLANTATION. HOWEVER, THERE ARE INSTANCES WHEN THOSE ORGANS AND/OR TISSUES ARE UNABLE TO BE TRANSPLANTED, IN WHICH CASE THEY CAN STILL BE DIRECTED TO HELP OTHERS IN NEED THROUGH RESEARCH INITIATIVES. RESEARCH AND DEVELOPMENT AIDS LIFELINK EFFORTS TO MAXIMIZE ALL GIFTS OF DONATION WITH A SHARED GOAL TO BENEFIT DONATION AND TRANSPLANTATION OUTCOMES THROUGH SCIENTIFIC ENDEAVORS.PUBLIC EDUCATION: PUBLIC AND PROFESSIONAL EDUCATION IN GEORGIA, FLORIDA, AND PUERTO RICO: THE PUBLIC AFFAIRS AND MULTICULTURAL DONATION EDUCATION PROGRAM TEAMS WORK TO PROVIDE DONATION EDUCATION AND INCREASE DONOR REGISTRATION ACROSS VARIOUS AUDIENCES INCLUDING DRIVER LICENSE ISSUING OFFICES, HOSPITALS, YOUTH, FAITH, AND MINORITY COMMUNITIES. LIFELINK UTILIZES AMBASSADORS THROUGHOUT OUR SERVICE AREAS TO SHARE DONATION AND TRANSPLANT STORIES WHILE ENCOURAGING INDIVIDUALS TO MAKE A LIFESAVING DECISION BY REGISTERING TO BE AN ORGAN AND TISSUE DONOR. RECOGNIZING THAT CERTAIN COMMUNITIES HAVE DIFFERENT PERCEPTIONS AROUND ORGAN DONATION, LIFELINK CREATED A PUBLIC EDUCATION CAMPAIGN, THE INFINITY CAMPAIGN. ORIGINALLY BORN IN PUERTO RICO AS THE INFINITO CAMPAIGN AND LAUNCHED WITH A PRIMARILY HISPANIC AUDIENCE. THE INFINITY CAMPAIGN REFRAMES ORGAN AND TISSUE DONATION THROUGH THE LENS OF LEGACY; THE LEGACY AN INDIVIDUAL CHOOSES FOR THEMSELVES WHEN THEY REGISTER AS A DONOR. TRADITIONALLY, DONATION OUTREACH HAS FOCUSED ON THE PROFOUND IMPACT TRANSPLANTATION HAS ON RECIPIENTS. INFINITY INTRODUCES A POWERFUL NEW PERSPECTIVE INSPIRED BY ONE OF THE LIFELINK FOUNDERS, WHO OFTEN ASKED: "WHAT IS YOUR LEGACY?" THE CAMPAIGN EXPLORES THAT QUESTION THROUGH THE LIVES AND STORIES OF PEOPLE WHO REGISTERED AS ORGAN AND TISSUE DONORS, HONORING THE IDEA THAT WHEN SOMEONE CHOOSES DONATION, THEIR STORY DOES NOT END. IT CONTINUES THROUGH THE MEMORIES OF THEIR LOVED ONES, THE LIVES OF THE RECIPIENTS THEY HELP, AND THE COMMUNITIES FOREVER CHANGED BY THEIR GENEROSITY. THIS CONCEPT IS VISUALLY REPRESENTED THROUGH THE INFINITY SYMBOL AND EXPRESSED THROUGH THE CAMPAIGN TAGLINE, "YOUR STORY CONTINUES." IN THE PUERTO RICO DONOR SERVICE AREA (DSA), THE INFINITO CAMPAIGN DEMONSTRATED A SIGNIFICANT INCREASE IN THE NUMBER OF DONOR REGISTRATIONS ACROSS THE ISLAND. WITHIN THE FIRST THREE MONTHS FOLLOWING THE CAMPAIGN LAUNCH IN OCTOBER 2023, REGISTRATIONS ROSE TO 128% OF THE SAME PERIOD IN 2022. THROUGHOUT 2024, DONOR REGISTRATIONS AVERAGED MONTHLY INCREASES OF 65% COMPARED TO THE PREVIOUS YEAR AND 2025 ILLUSTRATED THE STAYING POWER OF THIS CAMPAIGN, WITH AN AVERAGE MONTHLY INCREASE IN DONOR REGISTRATIONS AT 120% WHEN COMPARED TO 2024.REGARDING THE CAMPAIGN'S IMPACT AND REACH ACROSS SOCIAL MEDIA AND DIGITAL PLATFORMS, THE FIRST THREE MONTHS POST-LAUNCH GENERATED A REACH OF 9,392,221 WITH A CLICK-THROUGH RATE OF 0.17%. IN 2024, THE CAMPAIGN REACHED 14,636,340 USERS WITH A CLICK-THROUGH RATE OF 0.20%. IN 2025, WE OBSERVED A SUBSTANTIAL INCREASE IN IMPRESSIONS, REACHING 33,630,725 WITH A CLICK-THROUGH RATE OF 0.19%. THE SUCCESS OF THE CAMPAIGN IN PUERTO RICO LED US TO IMPLEMENT THE CAMPAIGN IN THE LIFELINK OF FLORIDA AND LIFELINK OF GEORGIA DSAS.IN FLORIDA AND GEORGIA, THE INFINITY CAMPAIGN CONTINUED ITS STRONG PERFORMANCE, PARTICULARLY ACROSS SOCIAL MEDIA, STREAMING PLATFORMS, AND CONNECTED TV. SOCIAL MEDIA PLACEMENTS ONCE AGAIN SIGNIFICANTLY EXCEEDED BENCHMARKS. ONLINE VIDEO COMPLETION RATES EXCEEDED EXPECTATIONS; STREAMED ADS ON CONNECTED TVS, LAPTOPS AND MOBILE DEVICES ACHIEVED COMPLETION RATES AS HIGH AS 98%, AND STREAMING AUDIO OUTPERFORMED INDUSTRY STANDARDS. THESE RESULTS VALIDATED BOTH THE CREATIVE APPROACH AND THE STRATEGIC USE OF MULTILINGUAL, COMMUNITY-CENTERED MESSAGING TAILORED TO DIVERSE AUDIENCES.GEORGIA HAS ONE OF THE LARGEST AFRICAN AMERICAN POPULATIONS IN THE COUNTRY, A FAST-GROWING HISPANIC POPULATION, MAJOR URBAN CENTERS, DEEPLY RURAL COMMUNITIES, AND A STRONG YOUTH POPULATION SPREAD ACROSS MANY SCHOOL DISTRICTS.OUR PUBLIC EDUCATION MODEL IN GEORGIA REFLECTS THIS COMPLEXITY WITH A DEDICATED MULTICULTURAL DONATION EDUCATION PROGRAM (MDEP), PRIMARILY RESPONSIBLE FOR OUTREACH TO AFRICAN AMERICAN POPULATIONS IN BOTH METRO ATLANTA AND RURAL GEORGIA FROM ALL BACKGROUNDS.MDEP PRIORITIZES OUTREACH IN AFRICAN AMERICAN CHURCHES, COMMUNITY GROUPS, NEIGHBORHOOD ORGANIZATIONS, COLLEGES, AND CIVIC NETWORKS, WITH PRESENTATIONS AND PARTNERSHIPS TAILORED TO THE UNIQUE EXPERIENCES OF THESE COMMUNITIES. LIKEWISE, OUTREACH IN GEORGIA'S HISPANIC COMMUNITIES INCORPORATES BILINGUAL MATERIALS AND CULTURALLY ALIGNED MESSAGING CRAFTED SPECIFICALLY FOR HISPANIC FAMILIES WHO CALL GEORGIA HOME.ONE KEY MDEP PROGRAM INVOLVES CLOSE ALIGNMENT WITH GEORGIA'S EIGHT HISTORICALLY BLACK COLLEGES AND UNIVERSITIES (HBCU), WHERE MDEP STAFF NOT ONLY CONDUCT ON CAMPUS EDUCATION ABOUT ORGAN DONATION, BUT THEY ALSO CULTIVATE THE NEXT GENERATION OF DIVERSE MEDICAL PROFESSIONALS. MEDICAL STUDENTS AT MOREHOUSE SCHOOL OF MEDICINE AT MOREHOUSE COLLEGE IN ATLANTA PARTICIPATE IN A PROGRAM THAT SHADOWS DONATION AND TRANSPLANTATION PROFESSIONALS IN THE LIFELINK OF GEORGIA DONOR CARE UNIT, AND THIS PROGRAM RECENTLY EXPANDED TO INCLUDE NURSING STUDENTS AT FT. VALLEY STATE UNIVERSITY AND ALBANY STATE UNIVERSITY. THIS PROGRAM, PART OF A NATIONAL INITIATIVE DRIVEN BY DR. CLIVE CALENDAR, A PIONEER IN TRANSPLANTATION WHO WAS THE FIRST TO BRING A TRANSPLANT PROGRAM TO A HISTORICALLY BLACK MEDICAL SCHOOL AND THE THIRD BLACK TRANSPLANT SURGEON IN THE COUNTRY, OFFERS FUTURE CAREGIVERS' INSIGHT INTO CAREER PATHS IN THE MEDICAL FIELD THEY MIGHT NOT HAVE PREVIOUSLY CONSIDERED AND ALSO BUILDS TRUST WITHIN MULTICULTURAL COMMUNITIES. 168447729 1 0 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 1 0 0 0 0 0 1 1 1 0 0 1 X 410 0 1 820 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 18 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 FL GA X X PATRICK BRISLEY CFO 8132532640 9661 DELANEY CREEK BOULEVARD TAMPA FL 33619 STEPHANIE HERNANDEZ PRESIDENT & CEO 40.00 2.00 X X 575348 0 337814 VICTOR BOWERS MD VICE CHAIR, MEDICAL DIRECTOR OPO 40.00 2.00 X 375604 0 72842 THOMAS PEARSON MD DIRECTOR, MEDICAL DIRECTOR LLGA 20.00 2.00 X 84903 0 31428 JOEL VAN SICKLER MD DIRECTOR, ASSOC MEDICAL DIR LLFL 20.00 2.00 X 55832 0 28564 ESTHER TORRES DIRECTOR, MEDICAL DIRECTOR OPO PR 20.00 0.00 X 79389 0 30691 JEAN DAVIS CHAIR (TERM END 5/2025) 2.00 0.00 X X 2250 0 0 HAROLD MULLIS JR ESQUIRE DIRECTOR 2.00 0.00 X 2250 0 0 JEFFREY L SEAVEY CFP DIRECTOR 2.00 0.00 X 1500 0 0 J DAVID VEGA MD DIRECTOR 2.00 0.00 X 1500 0 0 DEBORAH WINEGARD JD DIRECTOR 2.00 0.00 X 2250 0 0 JAMES J WYNN MD DIRECTOR 2.00 0.00 X 2250 0 0 WILLIAM CLEVELAND DIRECTOR 2.00 0.00 X 750 0 0 DARA SIMON DIRECTOR 2.00 0.00 X 1500 0 0 CHRISTINA KLEIN DIRECTOR 2.00 0.00 X 1500 0 0 BENJAMIN JAMES DIRECTOR 2.00 0.00 X 1500 0 0 ARNOLD MIGNUCCI DIRECTOR 2.00 0.00 X 1500 0 0 MARTY SELLERS DIRECTOR (TERM END 11/08/2024) 2.00 0.00 X 1500 0 0 SHANNON HOLTHAUS DIRECTOR 2.00 0.00 X 2250 0 0 LARRY JONES DIRECTOR 2.00 2.00 X 2250 0 0 PATRICK BRISLEY TREASURER & CFO 40.00 2.00 X 288729 0 58779 THERESA DALY EXEC DIR, OPO OPERATIONS 40.00 0.00 X 338708 0 68614 SUSAN RABEL VP EXEC DIRECTOR 40.00 0.00 X 262162 0 55312 KATHERINE PAYNE EXEC DIRECTOR LLGA (THRU 12/13/24) 40.00 0.00 X 259817 0 38472 HOPE WEED EXEC DIRECTOR LLGA 40.00 0.00 X 191502 0 42691 GUILLERMINA SANCHEZ EXEC DIRECTOR LLPR 40.00 0.00 X 187368 0 42893 MICHAEL CONSILVIO EXEC DIRECTOR GENERAL MGR 40.00 0.00 X 379703 0 72592 JOHN LUNZ EXEC DIRECTOR IMMUNOLOGY LAB 40.00 0.00 X 368782 0 124497 JACENTHA BUGGS ORGAN RECOVERY SURGEON 40.00 0.00 X 351596 0 58242 MARK P STRONG SR VP, ASSOC EXEC DIRECTOR 40.00 0.00 X 286542 0 58978 HUSSEIN OSMAN MOHAMED ORGAN RECOVERY SURGEON 40.00 0.00 X 283684 0 48983 CATHERINE GEBHART DIRECTOR, IMMUNOLOGY LAB 40.00 0.00 X 282650 0 64628 BRAD BASSLER VP OPS, ASSOC EXEC DIRECTOR 40.00 0.00 X 270847 0 57034 4947916 0 1293054 161 0 1 0 PHYSICIANS AIR TRANSPORT LLC 114 LOTUS PLACE HOT SPRINGS AR 71901 ORGAN AIR TRANSPORTATION 3190612 LIFE GIVING RESOURCE INC 1961 N 500 EAST OREM UT 84097 CONTRACTED TEMP LABOR SERVICES 2420566 EUROFINS DONOR & PRODUCT TESTING 6933 S REVERE PKWY CENTENNIAL CO 80112 LAB TESTING 2053475 NORA (NATIONWIDE ORGAN RECOVERY TRANSPOR 3805 E MAIN STREET SUITE E ST CHARLES IL 60174 DONOR ORGAN TRANSPORTATION 1639437 AUGUSTA AVIATION 1775 HIGHLAND AVE AUGUSTA GA 30904 ORGAN AIR TRANSPORTATION 1221770 40 ORGAN PLACEMENT 621991 116421016 116421016 TISSUE PLACEMENT 621991 51164636 51164636 IMMUNOLOGY LAB 621500 12082199 12082199 179667851 10896440 10896440 68505747 53438603 9547 15067144 -9547 15057597 15057597 ALLOGRAFT WAREHOUSING 621991 149845 149845 149845 205771733 179667851 149845 25954037 X 240532 240532 4366705 3118263 1248442 336613 336613 58446202 55411323 3034879 5189853 4920365 269488 17926565 16900557 1026008 4573686 4259584 314102 571290 571290 130523 130523 391238 391238 344365 344365 40719872 40520794 199078 4469587 4469587 4832327 4716143 116184 2442905 2092733 350172 3431880 2685715 746165 3960004 3656287 303717 507702 500545 7157 2856 2856 2847292 2763127 84165 1129235 1129235 MEDICAL SUPPLIES 21425976 21425976 DONATED PROPERTY EXPENS 23671 23671 SETTLEMENT 18750 18750 UBI TAX 11820 11820 178341449 168447729 9893720 0 12962537 12772942 29068820 32406593 21622354 23977049 658207 655233 69867306 44113769 27329903 25753537 196800286 220923660 200221 1071677 238421 222924 2740163 3325835 291620912 321109450 38064476 44530637 273821 1531811 1242894 39870108 45773531 X 251025807 274610922 724997 724997 251750804 275335919 291620912 321109450 27430284 -3845169 0 X X 0 1 X 1 0 X 147056983 148959426 152642230 158934068 179667851 787260558 147056983 148959426 152642230 158934068 179667851 787260558 0 0 0 787260558 3286494 7827239 7552893 8451386 10896440 38014452 28397 38841 27540 28479 22474 145731 3314891 7866080 7580433 8479865 10918914 38160183 150371874 156825506 160222663 167413933 190586765 825420741 0.95380 0.96050 0.04620 0.03950 X X 391238 391238 391238 391238 177950211 178676465 178341449 179067703 1000000 1000000 250000 250000 0 0 0 0 1000000 1000000 1000000 1000000 4000000 6000000 190313 129825 225304 391238 936680 250000 250000 250000 250000 1000000 1500000 5182449 5182449 49422051 32614897 16807154 13499841 10051917 3447924 1762965 1446955 316010 25753537 LEASE LIABILITIES 1242894 1242894 X PART X, LINE 2: THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(A) AS AN ORGANIZATION DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE ("IRC") OF 1986, AS AMENDED AND FROM INCOME TAXES UNDER SECTION 220.13 OF THE STATE/TERRITORY STATUTES IN WHICH THE FOUNDATION OPERATES. CENTRAL AMERICA AND THE CARIBBEAN 0 0 ALTERNATIVE INVESTMENTS N/A 977583 EAST ASIA AND THE PACIFIC 0 0 BUSINESS INVESTMENT N/A 222924 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES SALE OF TISSUE 10994 EUROPE 0 0 PROGRAM SERVICES SALE OF TISSUE 71 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES SALE OF TISSUE 23 NORTH AMERICA 0 0 PROGRAM SERVICES SALE OF TISSUE 16229 0 0 0 0 0 0 1227824 0 1227824 1 0 1 1 1 1 SCHEDULE F, PART I, LINE 3: THE FOUNDATION'S INVESTMENT STRATEGY FOR ITS INVESTMENT RESERVES IS TO GENERATE INCOME, PROTECT THE ASSETS IN AN INFLATIONARY ENVIRONMENT, ENSURE THE PORTFOLIO IS PROPERLY DIVERSIFIED AND SEEK CAPITAL APPRECIATION. ACCORDINGLY, THE FOUNDATION MADE INVESTMENT COMMITMENTS INTO ALTERNATIVE FUNDS DOMICILED IN THE US AND THE CAYMAN ISLANDS OF $3,250,000 DURING THE FISCAL YEAR 2024, OF WHICH $950,372 HAS BEEN CONTRIBUTED TO FUNDS DOMICILED IN THE CAYMAN ISLANDS AS OF JUNE 30, 2025. SCHEDULE F, PART I, LINE 3: EFFECTIVE JANUARY 9, 2018, LIFELINK INVESTED IN AN OFFSHORE COMPANY (HCT REGENERATIVE CO., LTD.) BASED IN TAIWAN. LIFELINK PAID $242,739 FOR 581,824 SHARES OF COMMON STOCK IN HCT REGENERATIVE CO., LTD. (HCT). IN CONJUNCTION WITH THE INVESTMENT, LIFELINK ENTERED INTO A COLLABORATION AND SUPPLY AGREEMENT WHEREBY LIFELINK IS ENGAGED TO PROCURE AND PROVIDE TO HCT CERTAIN BONE AND TISSUE FOR HCT'S USE IN ITS OPERATIONS. IN CONSIDERATION OF THE SUPPORTS PROVIDED BY LIFELINK, HCT WILL PAY TO LIFELINK A ROYALTY BASED ON ANNUAL NET SALES OF CERTAIN ALLOGRAFTS BY HCT FOR THE PRECEDING CALENDAR YEAR. LIFELINK RECEIVED ROYALTY PAYMENTS FROM HCT OF $15,498 DURING THE FISCAL YEAR ENDED JUNE 30, 2025, WHICH WAS RECORDED AS A REDUCTION TO THE INVESTMENT. SCHEDULE F, PART I, LINE 3: TISSUE IS SOLD TO TISSUE BANKS AND HEALTH CARE PROVIDERS IN BARBADOS, CANADA, DOMINICAN REPUBLIC, GERMANY, JAPAN, KINGDOM OF SAUDI ARABIA, MALAYSIA, MEXICO, NEW ZEALAND, PERU, SOUTH KOREA, SWITZERLAND, TAIWAN, AND THE UNITED KINGDOM. ASIDE FROM COMMISSIONS PAID FOR TISSUE PLACEMENT TO DISTRIBUTORS IN CANADA AND SOME SMALL EXPENSES TO SUPPORT ACTIVITY IN KINGDOM OF SAUDI ARABIA, MALAYSIA, SOUTH KOREA, SWITZERLAND, AND THE UNITED KINGDOM, THERE ARE NO EXPENDITURES RELATED TO THE SALE OF TISSUE IN THESE REGIONS. SEE THE FOUNDATION'S PROGRAM SERVICE ACCOMPLISHMENTS ON FORM 990, PART III, LINE 4B. 1 LIFELINK LEGACY FUND 9661 DELANEY CREEK BLVD TAMPA FL 33619 593040982 501(C)(3) 192719 0 N/A N/A PROGRAM GRANT TAMPA HILLSBOROUGH ECONOMIC DEVELOPMENT CORPORATION 101 E KENNEDY BLVD STE 1750 TAMPA FL 33602 271010441 501(C)(3) 10000 0 N/A N/A PROGRAM GRANT 2 0 PART I, LINE 2: PAYMENTS FOR APPROVED GRANTS ARE BASED ON INCURRED EXPENSES THAT MEET THE REQUIREMENTS OF THE GRANT AND SUPPORT THE OVERALL MISSION OF THE FOUNDATION. ALL GRANTS ARE REVIEWED AND APPROVED BY MANAGEMENT AT LEAST ANNUALLY. X 1 1 X X X X X 0 1 0 0 0 0 0 1 0 STEPHANIE HERNANDEZ PRESIDENT & CEO 496950 0 70000 0 8398 0 314589 0 23225 0 913162 0 0 0 JOHN LUNZ EXEC DIRECTOR IMMUNOLOGY LAB 320312 0 41000 0 7470 0 101622 0 22875 0 493279 0 0 0 MICHAEL CONSILVIO EXEC DIRECTOR GENERAL MGR 341426 0 30000 0 8277 0 50367 0 22225 0 452295 0 0 0 VICTOR BOWERS MD VICE CHAIR, MEDICAL DIRECTOR OPO 342833 0 23966 0 8805 0 48695 0 24147 0 448446 0 0 0 JACENTHA BUGGS ORGAN RECOVERY SURGEON 332240 0 1000 0 18356 0 32950 0 25292 0 409838 0 0 0 THERESA DALY EXEC DIR, OPO OPERATIONS 305834 0 25000 0 7874 0 45049 0 23565 0 407322 0 0 0 PATRICK BRISLEY TREASURER & CFO 259708 0 24000 0 5021 0 36632 0 22147 0 347508 0 0 0 CATHERINE GEBHART DIRECTOR, IMMUNOLOGY LAB 274321 0 8000 0 329 0 39263 0 25365 0 347278 0 0 0 MARK P STRONG SR VP, ASSOC EXEC DIRECTOR 261054 0 22000 0 3488 0 36613 0 22365 0 345520 0 0 0 HUSSEIN OSMAN MOHAMED ORGAN RECOVERY SURGEON 272929 0 500 0 10255 0 25727 0 23256 0 332667 0 0 0 BRAD BASSLER VP OPS, ASSOC EXEC DIRECTOR 240879 0 24000 0 5968 0 32887 0 24147 0 327881 0 0 0 SUSAN RABEL VP EXEC DIRECTOR 240180 0 16000 0 5982 0 33165 0 22147 0 317474 0 0 0 KATHERINE PAYNE EXEC DIRECTOR LLGA (THRU 12/13/24) 237872 0 16712 0 5233 0 16193 0 22279 0 298289 0 0 0 HOPE WEED EXEC DIRECTOR LLGA 173153 0 14309 0 4040 0 20466 0 22225 0 234193 0 0 0 GUILLERMINA SANCHEZ EXEC DIRECTOR LLPR 169989 0 12000 0 5379 0 20746 0 22147 0 230261 0 0 0 PART I, LINE 1A THE FOUNDATION'S BENEFIT PROGRAM PERMITS A NOMINAL FITNESS MEMBERSHIP REIMBURSEMENT AS A STANDARD BENEFIT TO ALL EMPLOYEES OF THE ORGANIZATION, INCLUDING OFFICERS AND KEY EMPLOYEES. THESE MEMBERSHIPS ARE INCLUDED IN TAXABLE INCOME. PART I, LINE 4B THE FOUNDATION HAS A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP) WHICH PROVIDES CERTAIN EXECUTIVES DEFERRED COMPENSATION BENEFITS IF THEY PROVIDE SUBSTANTIAL FUTURE SERVICES TO THE ORGANIZATION. BENEFITS TO THE PARTICIPANT UNDER THIS PLAN ONLY VEST ON EVENT OF NORMAL RETIREMENT, DISABILITY, DEATH OR SERP TERMINATION, AS DEFINED. IF A PARTICIPANT WERE TO TERMINATE EMPLOYMENT BEFORE ONE OF THESE EVENTS THE PARTICIPANT WOULD FORFEIT HIS OR HER ENTIRE BENEFIT. SERP BENEFITS ARE REVIEWED AND APPROVED ANNUALLY BY THE COMPENSATION COMMITTEE IN A MANNER THAT QUALIFIES FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER FEDERAL TAX LAW. THE FOUNDATION INCURRED EXPENSES OF $318,354 UNDER THE SERP DURING THE 2024 CALENDAR YEAR AS FOLLOWS: STEPHANIE HERNANDEZ, $264,223 JOHN LUNZ, $54,131 PART I, LINE 7 LIFELINK POLICIES PERMIT THE PAYMENT OF DISCRETIONARY ANNUAL BONUSES TO ALL STAFF. BONUSES ARE PART OF THE OVERALL COMPENSATION RECEIVED BY AN EMPLOYEE AND AS SUCH THE ORGANIZATIONAL BONUS POOL AS WELL AS THE BONUS AND TOTAL COMPENSATION OF THE CEO AND ALL DISQUALIFIED INDIVIDUALS ARE REVIEWED AND APPROVED FOR REASONABLENESS BY THE INDEPENDENT COMPENSATION COMMITTEE IN A MANNER THAT QUALIFIES FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER FEDERAL TAX LAW. BRAD T BASSLER SON-IN-LAW OF BOARD MEMBER 336613 COMPENSATION FOR EMPLOYMENT WHICH IS REVIEWED FOR REASONABLENESS BY THE INDEPENDENT COMPENSATION COMMITTEE IN A MANNER THAT QUALIFIES FOR REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER FEDERAL TAX LAW. SEE SCHEDULE O DISCLOSURE IN RESPONSE TO FORM 990, PART VI, SECTION B, LINE 15. 0 ARNOLD MIGNUCCI BOARD MEMBER IS A PARTNER IN A LAW FIRM UTILIZED BY THE FOUNDATION 131250 ATTORNEY FEES 0 FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: LIFELINK FOUNDATION WAS ESTABLISHED MORE THAN 40 YEARS AGO WITH A MISSION TO HONOR THE LIVES OF ORGAN AND TISSUE DONORS BY PROVIDING RENEWED HOPE TO AS MANY PEOPLE AS POSSIBLE THROUGH ORGAN AND TISSUE TRANSPLANTATION. OUR ORGAN PROCUREMENT ORGANIZATIONS, LIFELINK OF FLORIDA, LIFELINK OF GEORGIA, AND LIFELINK OF PUERTO RICO, SUPPORT, AND GUIDE FAMILIES THROUGH THE DONATION PROCESS AS THEY ESTABLISH THEIR LOVED ONE'S LEGACY THROUGH ORGAN DONATION. THE COLLABORATIVE EFFORTS OF THE LIFELINK OPOS, TOGETHER WITH THOSE OF LIFELINK TISSUE BANK AND LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY, GIVE HOPE TO THE MORE THAN 100,000 PATIENTS WAITING FOR A LIFESAVING ORGAN TRANSPLANT, AND TENS OF THOUSANDS MORE WHO COULD BENEFIT FROM TISSUE TRANSPLANTATION. LIFELINK LEGACY FUND IS A SEPARATE ORGANIZATION THAT CONTRIBUTES TO THE MISSION OF LIFELINK FOUNDATION THROUGH FUND DEVELOPMENT TO PROVIDE GRANTS FOR RESEARCH, PUBLIC EDUCATION, AND OTHER PROGRAMS THAT SUPPORT ORGAN AND TISSUE DONATION AND TRANSPLANTATION. OUR MISSION IS CARRIED OUT WITH COMPASSION BY TEAM MEMBERS WHO WORK TIRELESSLY TOWARDS THE GOAL WE SHARE WITH OUR PROFESSIONAL PARTNERS, THE FAMILIES WE SERVE, AND OUR COMMUNITIES: WE HONOR LIFE BY SAVING LIVES. FORM 990, PART V, LINE 2A: THE ORGANIZATION FILED 711 FORMS W-2 FOR 2024 PLUS AN ADDITIONAL 109 ON THE EQUIVALENT PUERTO RICO FORM FOR A TOTAL OF 820 EMPLOYEES FOR THE 2024 CALENDAR YEAR. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE HAS THE AUTHORITY TO EXERCISE THE POWERS OF THE BOARD OF GOVERNORS BETWEEN BOARD MEETINGS. THE COMMITTEE DOES NOT HAVE THE AUTHORITY TO: (1) ADOPT, AMEND, OR REPEAL THE BYLAWS OR ARTICLES OF INCORPORATION, OR (2) APPROVE ANY EXPENSES, NOT ALREADY PROVIDED FOR IN THE ANNUAL BUDGET, IN EXCESS OF $1,500,000. THE COMMITTEE IS REQUIRED TO REPORT AT EACH MEETING OF THE BOARD OF GOVERNORS ON ITS ACTIVITIES SINCE THE LAST MEETING OF THE BOARD OF GOVERNORS. FORM 990, PART VI, SECTION B, LINE 11B AN ELECTRONIC COPY OF THE FOUNDATION'S FORM 990 IS PROVIDED TO THE AUDIT COMMITTEE, PRESIDENT, AND CFO FOR PRELIMINARY REVIEW. AN ELECTRONIC COPY OF FORM 990 IS THEN DISTRIBUTED TO THE ENTIRE GOVERNING BOARD PRIOR TO ISSUANCE. FORM 990, PART VI, SECTION B, LINE 12C UPON NEW HIRE AND ANNUALLY THEREAFTER, ALL BOARD MEMBERS AND LIFELINK STAFF SHALL REVIEW THE CONFLICT OF INTEREST POLICY AND COMPLETE THE CONFLICT OF INTEREST STATEMENT. THE ANNUAL CERTIFICATION REQUIRES THE DISCLOSURE OF ANY CONFLICTS OF INTEREST THAT MAY EXIST WHICH ARE THEN ROUTED TO THE CORPORATE COMPLIANCE DEPARTMENT. THE CORPORATE COMPLIANCE DEPARTMENT SHALL REVIEW ALL STATEMENTS AND THOSE INDICATING A POTENTIAL CONFLICT SHALL BE REVIEWED BY THE CORPORATE COMPLIANCE OFFICER OR CEO/PRESIDENT TO DETERMINE WHAT ACTION, IF ANY, IS NECESSARY INCLUDING ADDITIONAL REVIEW BY THE EXECUTIVE COMMITTEE OF THE BOARD OF GOVERNORS AS NEEDED. IF AT ANY TIME DURING THE YEAR, THE INFORMATION IN THE ANNUAL STATEMENT CHANGES MATERIALLY, THE EMPLOYEE OR VOTING BOARD MEMBER SHALL DISCLOSE SUCH CHANGES AND REVISE THE ANNUAL CONFLICT OF INTEREST STATEMENT. FORM 990, PART VI, SECTION B, LINE 15 AN INDEPENDENT COMPENSATION COMMITTEE ACTING ON BEHALF OF THE GOVERNING BOARD IS RESPONSIBLE FOR REVIEWING AND APPROVING THE TOTAL COMPENSATION OF ALL OFFICERS, DIRECTORS, KEY EMPLOYEES AND ANY RELATED FAMILY MEMBERS AT LEAST ANNUALLY. THIS REVIEW INCLUDES A DETAILED ANALYSIS OF COMPARABLE DATA FROM INDUSTRY SURVEYS, FORM 990S, AND STUDIES FROM A THIRD-PARTY CONSULTANT. THE INDEPENDENT CONSULTING FIRM PREPARES A FULL MARKET STUDY EVERY THREE YEARS. THE MOST RECENT MARKET STUDY WAS COMPLETED IN JUNE 2025. THE COMPENSATION COMMITTEE ANNUALLY REVIEWS AND APPROVES THE COMPENSATION AND BENEFITS PROVIDED TO EACH OFFICER AND KEY EMPLOYEE LISTED ON THE FORM 990 AND CONDUCTS THE REVIEW AND APPROVAL IN A MANNER DESIGNED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER FEDERAL TAX LAW. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC AS IT IS NOT REQUIRED TO BY LAW. PART VI, SECTION B: CORPORATE COMPLIANCE PROGRAM: THE OBJECTIVE OF THE CORPORATE COMPLIANCE DEPARTMENT IS TO PROVIDE GUIDANCE TO ALL EMPLOYEES AS THEY CARRY OUT THEIR DAILY ACTIVITIES WITHIN APPROPRIATE ETHICAL AND LEGAL STANDARDS. CORPORATE COMPLIANCE PROVIDES AN IN-HOUSE COMPLIANCE SERVICE THAT EFFECTIVELY SUPPORTS EACH DIVISION IN THEIR DUTY TO COMPLY WITH RELEVANT LAWS AND INTERNAL PROCEDURES. CORPORATE COMPLIANCE REVIEWS BEST PRACTICES FROM OUTSIDE RESOURCES TO ENSURE POLICIES AND PROCEDURES ARE UPDATED AS NECESSARY. ANNUAL POLICY TRAINING IS PROVIDED TO ALL EMPLOYEES AS IT IS AN IMPORTANT PART OF THEIR PROFESSIONAL DEVELOPMENT AND COMMITMENT TO ACHIEVE THE FOUNDATION'S MISSION. CORPORATE COMPLIANCE ALSO MONITORS THE EMPLOYEE HOTLINE, WHICH ALLOWS EMPLOYEES TO REPORT POTENTIAL COMPLIANCE CONCERNS ANONYMOUSLY. CORPORATE COMPLIANCE INVESTIGATES THE HOTLINE CONCERNS THOROUGHLY AND PROMPTLY. CORPORATE COMPLIANCE IS RESPONSIBLE FOR DEVELOPING AND MAINTAINING AN EFFICIENT AND EFFECTIVE PROGRAM OF INTERNAL AUDITING AND MONITORING TO ENHANCE OUR CAPACITY TO MANAGE RISK, INVESTIGATE EMERGING ISSUES AND TRENDS AND DETECTING DEVIATIONS FROM ESTABLISHED INTERNAL CONTROLS. CORPORATE COMPLIANCE IS ALSO INVOLVED WITH ASSISTING THE INFORMATION SYSTEMS DEPARTMENT WITH LIFELINK CYBER SECURITY STRATEGIES. ETHICAL AND MORAL BEHAVIOR IS EXPECTED FROM ALL EMPLOYEES. THE CORPORATE COMPLIANCE DEPARTMENT EMBODIES DEDICATION TO THE HIGHEST STANDARDS OF ETHICAL BEHAVIOR, EXPRESSED THROUGH CORPORATE CULTURE AND THROUGH ADHERENCE TO THE LAW. LIFELINK IS COMMITTED TO DETECTING AND CORRECTING ANY UNINTENTIONAL OR DELIBERATE CONDUCT THAT IS INCONSISTENT WITH THESE PRINCIPLES. FORM 990, PART IX, LINE 11G COMMISSIONS: PROGRAM SERVICE EXPENSES 1,048,342. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,048,342. DONOR HOSPITAL COSTS: PROGRAM SERVICE EXPENSES 11,427,975. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 11,427,975. DONOR RELATED PHYSICIAN FEES: PROGRAM SERVICE EXPENSES 5,336,990. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 5,336,990. DONOR RELATED TRANSPORTATION: PROGRAM SERVICE EXPENSES 9,804,433. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 9,804,433. DONOR SEROLOGIES AND LAB TESTS: PROGRAM SERVICE EXPENSES 1,099,841. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,099,841. DONOR TISSUE TYPING: PROGRAM SERVICE EXPENSES 1,043,924. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,043,924. UNIFORM SERVICES: PROGRAM SERVICE EXPENSES 202,600. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 202,600. PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 2,017,981. MANAGEMENT AND GENERAL EXPENSES 198,929. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,216,910. TEMPORARY LABOR: PROGRAM SERVICE EXPENSES 5,200,544. MANAGEMENT AND GENERAL EXPENSES 149. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 5,200,693. TISSUE ACQUISITION COSTS: PROGRAM SERVICE EXPENSES 1,834,164. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,834,164. PERFUSION SERVICES: PROGRAM SERVICE EXPENSES 1,504,000. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,504,000. LIFELINK LEGACY FUND INC 9661 DELANEY CREEK BOULEVARD TAMPA FL 33619 593040982 TO SUPPORT THE LIFELINK FOUNDATION MISSION FL 501(C)(3) LINE 12D, III-O LIFELINK FOUNDATION INC 1 0 1 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 1 1 LIFELINK LEGACY FUND D 716130 LOAN BALANCE LIFELINK LEGACY FUND B 192719 CASH TRANSFERS LIFELINK LEGACY FUND 9661 DELANEY CREEK BOULEVARD TAMPA FL 33619 593040982 X 0 0 0 726254 726254 133938 33485 0 0 0